Clinical Trials Directory

Trials / Completed

CompletedNCT03175757

A Study to Evaluate the Effects of a Turmeric and Black Cumin Seed Formulation on Cholesterol Levels

A Randomized, Single-blind, Placebo-controlled Study to Evaluate the Effects of a Turmeric and Black Cumin Seed Formulation on Cholesterol Levels Among Generally Healthy Participants

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
33 (actual)
Sponsor
Supplement Formulators, Inc. · Industry
Sex
All
Age
40 Years – 75 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to assess the effects of a turmeric and black cumin seed formulation on cholesterol levels.

Detailed description

This study is a randomized, single-blind, placebo-controlled study to evaluate the effects of a turmeric and black cumin seed formulation on cholesterol levels. Each subject will receive a specific dose of the formulation or placebo twice daily. Participants will undergo assessments of blood tests, vital signs, body weight, waist circumference, hip circumference and waist-to-hip ratio with completion of a questionnaire. The primary objective of the study is to assess the effects of the turmeric and black cumin seed formulation on fasting levels of Total Cholesterol. Secondary objectives include assessment of the effects of turmeric and black cumin seed formulation on: fasting levels of: LDL Cholesterol, parameters in the NMR LipoProfile®, Oxidized LDL, Triglycerides, HDL cholesterol, C-reactive protein, blood glucose, Insulin and Hemoglobin A1c, as well as the assessments of the values/scores of body weight, waist circumference, hip circumference, waist-to-hip ratio, blood pressure and the SF-36 survey scores.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTTurmeric and Black Cumin SeedTurmeric and Black Cumin Seed formulation
DIETARY_SUPPLEMENTPlaceboPlacebo

Timeline

Start date
2017-05-12
Primary completion
2018-08-10
Completion
2018-08-16
First posted
2017-06-05
Last updated
2018-09-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03175757. Inclusion in this directory is not an endorsement.